Validation of the HYPONUT Product
- Conditions
- Peanut Allergy
- Interventions
- Other: Hyponut
- Registration Number
- NCT03849079
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The HYPONUT product was previously validated in a laboratory setting ("Procédé de préparation d'aliment hypoallergénique", n° FR1250977) on 2012. A international patent was then obtained on 2013. Through the present study, the investigators would like to prove that the hypoallergenicity of the product is sustained in a clinical setting. Patients allergic to peanuts currently undergo in vivo tests to confirm their allergy: skin prick tests, and oral food challenges. In vitro tests are also performed (i.e. IgE levels for peanut and peanut components). The follow-up of patients consists in regular yearly or semestral evaluations. During one of these evaluation, the investigators will skin tests patients with the hyponut product to verify if they are sensitized to this last one as well. When skin tests will be negative, the investigators will propose to patients to take some of the product to verify its tolerability as well.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Hyponut Hyponut -
- Primary Outcome Measures
Name Time Method Skin Prick Tests evaluation day patient enrolled
- Secondary Outcome Measures
Name Time Method Oral food challenge evaluation day patient enrolled
Trial Locations
- Locations (1)
University Hospital
🇫🇷Montpellier, Hérault, France